Witholytin®: Unlocking Natural Stress Relief backed by Research

According to data, the global ashwagandha supplements market, valued at USD 670.57 million in 2023, is expected to grow at an 8.4% CAGR through 2030, driven by rising demand for natural solutions to help manage stress, anxiety, fatigue and more. Witholytin® is well-positioned to meet this demand, supported by a recent study showing a 45.81% reduction in fatigue and a 38.59% decrease in stress among adults experiencing low energy and moderate-to-high stress levels¹.

With concerns still growing around adulteration and labelling accuracy, strict methods and transparency are essential. While Witholytin® follows USP standards, our trusted partners, Verdure Sciences® has further validated a UHPLC−PDA method to measure 11 withanolides, demonstrating a commitment to quality and accountability.

Witholytin® is also the world’s first Alkemist Assured™ Ashwagandha, ensuring quality through rigorous testing for identity, potency, and contamination. 

A sub-analysis also examined hormone biomarkers in both men and women. It was found that men taking Witholytin® experienced a 12.87% increase in free testosterone (p = 0.048) and luteinizing hormone (p = 0.002) compared to the placebo group¹. These results are incredibly exciting and have prompted Verdure Sciences® to consider further research on specific populations that may benefit from ashwagandha supplementation, as its stress-reducing effects may vary based on factors such as age, sex, BMI, and more.

Witholytin® is a sustainably produced ashwagandha extract, standardised to 1.5% total withanolides from the roots. To learn more, visit our Witholytin® dedicated page or contact us.

_{References
(1) Smith SJ et al. (Sept 2023). Exploring the efficacy and safety of a novel standardized ashwagandha (Withania somnifera) root extract (Witholytin®).J Psychopharmacol. doi: 10.1177/02698811231200023.}